Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.
Contact

News & Events:

Revealing the true targets for next generation immunotherapies.
Learn More

Epitopea Featured in GEN

Date: April 1, 2026 |
Engineering Biology to Fight Cancer Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the […]
Read More

Epitopea Featured in BiotechTV

Date: May 9, 2025 |
Cambridge, UK based Epitopia is helping Merck (MSD) discover tumor associated antigens from the non-coding regions of the genome using […]
Read More

Epitopea Featured in Fierce Biotech

Date: February 19, 2025 |
Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens Merck & Co. has penned a $300 million biobucks-per-product […]
Read More

Epitopea Featured in Endpoints

Date: February 19, 2025 |
Start­ up that mines ‘junk DNA ’ se­cures R&D deal with Mer­ck By Ayisha Sharma, 19 February 2025 Epi­topea has […]
Read More

Epitopea Featured in Cambridge Independent

Date: November 4, 2024 |
Epitopea’s $31m pre-Series A is boost for RNA immunotherapies clinical trials Epitopea’s transatlantic business model has been boosted by a […]
Read More

Epitopea wins the 3rd annual Sweet BioPharma Day competition

Date: April 14, 2023 |
Epitopea wins the 3rd annual Sweet BioPharma Day competition LAVAL, Québec--(BUSINESS WIRE)--BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations, […]
Read More

Epitopea Featured in BioWorld

Date: May 11, 2022 |
Epitopea closes $14M seed round for tumor antigen discovery Epitopea Ltd. raised $13.6 million in seed financing to take forward […]
Read More
Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2026 Epitopea Ltd | All Rights Reserved
Created by FDM Digital